迈瑞医疗筹划发行H股股票并在香港联交所上市

Core Viewpoint - Mindray Medical announced plans to issue overseas listed foreign shares (H-shares) and list on the main board of the Hong Kong Stock Exchange to support business development and enhance international capital operations [1] Group 1 - The company aims to deepen its international strategy and improve capital strength through this issuance [1] - The decision follows thorough research and analysis by the company [1] - The company will consider the interests of existing shareholders and the conditions of domestic and foreign capital markets when selecting the timing and window for the issuance [1]